These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 805409)

  • 1. [Letter: Encephalopathies during treatment with bismuth or the mishaps of"conjugated" bismuth therapy].
    Raverdy P; Smagghe A; Marie JP; Prinseau J
    Nouv Presse Med; 1975 Apr; 4(14):1050. PubMed ID: 805409
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].
    Buge A; Rancurel G; Poisson M; Dechy H
    Nouv Presse Med; 1974 Oct; 3(36):2315-20. PubMed ID: 4218313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter: Encephalopathies due to insoluble salts of bismuth].
    Goule JP; Husson A; Fondimare A; Rapoport F; Lebreton M; Lajarige V
    Nouv Presse Med; 1975 May; 4(18):1366. PubMed ID: 1153303
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Reversible acute myoclonic encephalopathies after bismuth salt ingestion].
    Fressinaud L; Emile J; Charbonnel A; Féve JR
    Nouv Presse Med; 1975 Mar; 4(12):885. PubMed ID: 1136684
    [No Abstract]   [Full Text] [Related]  

  • 5. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)].
    Eichler I
    Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Myoclonic encephalopathies caused by bismuth salts].
    Tournilhac M; Flori B; Dordain G; Roye JM
    Nouv Presse Med; 1975 Feb; 4(6):430. PubMed ID: 1129100
    [No Abstract]   [Full Text] [Related]  

  • 7. [Letter: Myoclonic encephalopathy and bismuth salt poisoning].
    Cambier J; Mason M; Dairou R
    Nouv Presse Med; 1974 Dec; 3(44):2662. PubMed ID: 4459861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychiatric aspects of encephalopathy caused by bismuth salts].
    Bertaud M; Mangin P; Charlin A
    Ann Med Psychol (Paris); 1976 May; 1(5):717-21. PubMed ID: 970827
    [No Abstract]   [Full Text] [Related]  

  • 9. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Too much bismuth].
    Barbizet J; Degos JD; Lamotte J
    Ann Med Interne (Paris); 1978 Jan; 129(1):77-80. PubMed ID: 637465
    [No Abstract]   [Full Text] [Related]  

  • 12. [Osteo-articular lesions observed in acute bismuth encephalopathies. A propos of 2 cases].
    Garcia JL; Penin F; Weber M; Regent MC; Cuny G
    Rev Rhum Mal Osteoartic; 1980 Apr; 47(4):275-80. PubMed ID: 7384730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology].
    Olive G
    Therapie; 1980; 35(3):305-6. PubMed ID: 6775384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bismuth-induced encephalopathies. Report and commentaries apropos of 15 cases in the Lyon area].
    Moindrot J; Evreux JC; Savet JF; Aimard G
    Lyon Med; 1977 Dec; 238(20):537-41. PubMed ID: 599952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: Bismuth encephalopathy. 4 cases observed in a general medical department].
    Aimez P; Bigorie B; Bour H; Gazengel J; Guy-Grand B
    Nouv Presse Med; 1975 May; 4(20):1505. PubMed ID: 1215151
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute fatal encephalopathy with osteonecrosis of both humeral heads following the ingestion of minimal doses of insoluble bismuth salts (author's transl)].
    Lhermitte F; Mallecourt J; Chedru F; Kuperwasser B; Glaser P
    Nouv Presse Med; 1978 Jun; 7(24):2170-1. PubMed ID: 683868
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iatrogenic myoclonic encephalopathies caused by bismuth salts].
    Loiseau P; Henry P; Jallon P; Legroux M
    J Neurol Sci; 1976 Feb; 27(2):133-43. PubMed ID: 1249582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bismuth treatment and blood bismuth levels].
    Hillemand P; Pallière M; Laquais B; Bouvet P
    Sem Hop; 1977 Sep; 53(31-32):1663-9. PubMed ID: 198893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bismuth encephalopathies outside France (author's transl)].
    Lagier G
    Therapie; 1980; 35(3):315-7. PubMed ID: 7423419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.